There are 2867 resources available
1773P - Prediction of neoadjuvant chemotherapy response in muscle-invasive bladder cancer: A machine learning approach
Presenter: Eugene Shkolyar
Session: Poster session 18
1774P - Association of CREBBP mutation with favorable outcome with immune checkpoint inhibitors in bladder cancer
Presenter: Wang Sheng
Session: Poster session 18
1775P - Prevalence of PD-L1 high expression in advanced urothelial carcinoma (aUC): Results from the PREVAIL prospective cohort study
Presenter: Petros Grivas
Session: Poster session 18
1776P - Treatment outcomes and FGFR alterations in unresectable locally advanced or metastatic urothelial cancer in Taiwan
Presenter: Jian-Ri Li
Session: Poster session 18
1777P - 13 genes panel validation to assess minimal residual disease through urinary tumor DNA in muscle-invasive bladder cancer patients
Presenter: Gianluigi De Renzi
Session: Poster session 18
1778P - Comparative genomic alterations (GA) landscape in urothelial carcinoma of the bladder (UCB) in patients of South Asian ancestry (SAS)
Presenter: Philippe Spiess
Session: Poster session 18
1779TiP - Phase II clinical study evaluating the efficacy and safety of disitamab vedotin in patients (pts) with HER2-expressing urothelial carcinoma (RC48G001)
Presenter: VADIM KOSHKIN
Session: Poster session 18
1780TiP - A phase II clinical study to assess efficacy of induction ipilimumab/nivolumab to spare the bladder in urothelial bladder cancer (INDI-BLADE)
Presenter: Chantal Stockem
Session: Poster session 18
CN3 - An integrated care model for the management of patients receiving oral anti-cancer agents (OAM) by an advanced nurse practitioner (ANP): Planning and development process
Presenter: Janice Richmond
Session: Poster session 19
Resources:
Abstract
CN4 - iGestSaúde: Portuguese mobile application for the self-management of symptoms associated with chemotherapy treatment
Presenter: Bruno Magalhaes
Session: Poster session 19
Resources:
Abstract